Vertex (VERX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.38%. A quarter ago, it was expected that this company would post earnings of $0.14 per share when it actually produced earnings of $0.15, delivering a surprise of 7.14%.Over the last four quarters, the company has surpas ...

Exhibit 99.1 Vertex Announces First Quarter 2025 Financial Results KING OF PRUSSIA, PA – May 7, 2025: Vertex, Inc. (NASDAQ: VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced financial results for its first quarter ended March 31, 2025. "Vertex continued to perform well in the first quarter, setting us up for a strong 2025," said David DeStefano, Vertex's President, Chief Executive Officer and Chairperson of the Board. "Our financial results were in line ...

KING OF PRUSSIA, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its first quarter ended March 31, 2025. “Vertex continued to perform well in the first quarter, setting us up for a strong 2025,” said David DeStefano, Vertex’s President, Chief Executive Officer and Chairperson of the Board. “Our financial results were in line with our expectations for the quarter, and we m ...

Vertex Pharmaceuticals' (VRTX -9.39%) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date. However, Vertex's shares plunged after the company announced its first-quarter results on Monday. Should investors throw in the towel on Vertex? I don't think so. Instead, the sell-off presents a fantastic opportunity to double up on this big biotech innovator. Dissecting Vertex's bad news The main bad news with Vertex's Q1 results was that the company ...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) reported decent Q1 earnings yesterday, despite falling short of analyst estimates for both revenue and earnings. Statistically, positive earnings surprises have shown strong predictive power of stock price movements in the short term, but asDilantha De Silva is an experienced equity analyst and investment researcher with over 10 years in the investment industry. He writes insightful articles for Seeking Alpha, GuruFocus, TipRanks, and ValueWalk, with a sig ...

Shares of Vertex Pharmaceuticals (VRTX -11.91%) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. The sharp decline came after the company announced its 2025 first-quarter results on Monday evening.Vertex reported Q1 revenue of $2.77 billion, up 3% year over year. It posted adjusted earnings of $1.24 billion, or $4.76 per share, up from $1.05 billion, or $4.06 per share, in the prior-year period. However, both top- and bottom-line numbers missed the consensus Wall Street estimates. In addition, Vertex reve ...

Here's our initial take on Vertex Pharmaceuticals' (VRTX -0.27%) first-quarter financial report.Key MetricsMetricQ1 2024Q1 2025Changevs. ExpectationsTotal revenue$2.69 billion$2.77 billion+3%MissedAdjusted earnings per share$4.76$4.06-15%MissedTrikafta/Kaftrio revenue$2.48 billion$2.54 billion+2%n/aOther revenue$207 million$225 million+9%n/aVertex Hits a Speed BumpVertex's first-quarter financial results didn't keep up with what investors have gotten used to seeing in recent quarters. Revenue in Q1 rose jus ...

I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up to Growth Stock Forum.Shares of Vertex Pharmaceuticals (NASDAQ: VRTX ) have been very resilient in the last six ...

KING OF PRUSSIA, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, today announced it has completed a strategic investment in Kintsugi, a San Francisco-based, AI-native startup focused on automating sales tax compliance for small and mid-size businesses (SMBs). Terms of the agreement include a $15 million minority investment representing a 10 percent ownership interest, as well as IP sharing and a commerci ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Vertex (VERX) . This company, which is in the Zacks Internet - Software industry, shows potential for another earnings beat.This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 10.71%.For the most recent quarte ...